Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene

Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene. Alport syndrome is a clinically and genetically heterogeneous nephropathy. The majority of cases are transmitted as an X-linked semidominant condition due to COL4A5 mutations. In this form males are more s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 2004-05, Vol.65 (5), p.1598-1603
Hauptverfasser: Pescucci, Chiara, Mari, Francesca, Longo, Ilaria, Vogiatzi, Paraskevi, Caselli, Rossella, Scala, Elisa, Abaterusso, Cataldo, Gusmano, Rosanna, Seri, Marco, Miglietti, Nunzia, Bresin, Elena, Renieri, Alessandra
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene. Alport syndrome is a clinically and genetically heterogeneous nephropathy. The majority of cases are transmitted as an X-linked semidominant condition due to COL4A5 mutations. In this form males are more severely affected than females. Less than 10% of cases are autosomal recessive due to mutation in either COL4A3 or COL4A4. In this rarer form, both males and females are severely affected. Only two cases of autosomal-dominant Alport syndrome have been reported, one due to a COL4A3 mutation and the other due to a COL4A4 mutation. Because of the paucity of the reported families, the natural history of autosomal-dominant Alport syndrome is mostly unknown. Four families with likely autosomal-dominant Alport syndrome were investigated. COL4A3 and COL4A4 genes were analyzed by denaturing high-performance liquid chromatography (HPLC). Automated sequencing was performed to identify the underlying mutation. Two families had a mutation in the COL4A4 gene and two in the COL4A3. Accurate clinical evaluation of family members showed interesting results. Affected individuals (22 persons) had a wide range of phenotypes from end-stage renal disease (ESRD) in the fifth decade to a nonprogressive isolated microhematuria. Finally, three heterozygous individuals (90, 22 and 11years old, respectively) were completely asymptomatic. This paper demonstrated that patients affected by autosomal-dominant Alport syndrome have a high clinical variability. Moreover, a reduced penetrance of about 90% (3 of 25) may be considered for the assessment of recurrence risk during genetic counseling of these families.
ISSN:0085-2538
1523-1755
DOI:10.1111/j.1523-1755.2004.00560.x